EUVIMEDEUVIMED entdecken
Crossref

Development and characterization of monoclonal antibodies against human CD20 in Balb/c mice

Koushan Sineh Sepehr, Behzad Baradaran, Jafar Majidi, Jalal Abdolalizadeh, Leili Aghebati, Fatemeh Zare Shahneh

Human Antibodies · 2013

DOI: 10.3233/hab-130263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Antibodies, 2013. Verfasst von Koushan Sineh Sepehr und 5 weiteren Autor:innen. Beteiligte Einrichtung: Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Die Arbeit wurde bisher 10-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAntibodies, MonoclonalAntigens, CD20B-LymphocytesCross ReactionsEnzyme-Linked Immunosorbent AssayFemaleHumansHybridomasImmunizationMiceMice, Inbred BALB CPeptidesPolyethylene GlycolsProtein Structure, TertiarySensitivity and SpecificitySpleen

Substanzen

Antibodies, MonoclonalAntigens, CD20PeptidesPolyethylene Glycols

Autor:innen und Institutionen

  • Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Zitieren

APA

Sepehr, K. S., Baradaran, B., Majidi, J., Abdolalizadeh, J., Aghebati, L., & Shahneh, F. Z. (2013). Development and characterization of monoclonal antibodies against human CD20 in Balb/c mice. Human Antibodies. https://doi.org/10.3233/hab-130263

Vancouver

Sepehr KS, Baradaran B, Majidi J, Abdolalizadeh J, Aghebati L, Shahneh FZ. Development and characterization of monoclonal antibodies against human CD20 in Balb/c mice. Human Antibodies. 2013. doi:10.3233/hab-130263

BibTeX
@article{Sepehr2013,
  author = {Sepehr, Koushan Sineh and Baradaran, Behzad and Majidi, Jafar and Abdolalizadeh, Jalal and Aghebati, Leili and Shahneh, Fatemeh Zare},
  title = {Development and characterization of monoclonal antibodies against human CD20 in Balb/c mice},
  journal = {Human Antibodies},
  year = {2013},
  doi = {10.3233/hab-130263}
}
Kostenlos starten →